| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Ion Channel Gating | 2 | 2018 | 22 | 0.91 | Why? |
| Potassium Channels, Tandem Pore Domain | 2 | 2018 | 11 | 0.78 | Why? |
| Cobicistat | 1 | 2020 | 172 | 0.78 | Why? |
| Stenotrophomonas maltophilia | 1 | 2019 | 63 | 0.77 | Why? |
| Tuberculosis, Urogenital | 1 | 2018 | 12 | 0.76 | Why? |
| Polyps | 1 | 2018 | 31 | 0.72 | Why? |
| Quinolones | 1 | 2019 | 167 | 0.70 | Why? |
| Information Theory | 1 | 2017 | 5 | 0.69 | Why? |
| Prophages | 1 | 2017 | 11 | 0.69 | Why? |
| Niacin | 1 | 2017 | 24 | 0.69 | Why? |
| Vibrio cholerae O1 | 1 | 2017 | 15 | 0.69 | Why? |
| Antimanic Agents | 1 | 2017 | 54 | 0.68 | Why? |
| Life Support Care | 1 | 2018 | 161 | 0.67 | Why? |
| Darunavir | 1 | 2020 | 477 | 0.65 | Why? |
| Osteoblasts | 2 | 2017 | 87 | 0.65 | Why? |
| HIV Protease Inhibitors | 1 | 2020 | 434 | 0.64 | Why? |
| Bronchitis | 1 | 2018 | 146 | 0.64 | Why? |
| Clinical Deterioration | 1 | 2020 | 473 | 0.61 | Why? |
| Folic Acid | 1 | 2017 | 172 | 0.61 | Why? |
| Nonlinear Dynamics | 1 | 2017 | 177 | 0.61 | Why? |
| Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2014 | 3 | 0.58 | Why? |
| Professional Competence | 1 | 2018 | 246 | 0.58 | Why? |
| Republic of Korea | 13 | 2021 | 5858 | 0.56 | Why? |
| Feedback | 1 | 2017 | 317 | 0.56 | Why? |
| Transcription Factors | 2 | 2018 | 784 | 0.56 | Why? |
| Organ Dysfunction Scores | 2 | 2020 | 1475 | 0.55 | Why? |
| Gram-Negative Bacterial Infections | 1 | 2019 | 398 | 0.54 | Why? |
| Muscle, Smooth, Vascular | 1 | 2014 | 86 | 0.53 | Why? |
| AMP-Activated Protein Kinases | 1 | 2014 | 93 | 0.53 | Why? |
| Calcification, Physiologic | 1 | 2013 | 14 | 0.52 | Why? |
| Fatty Acids, Omega-3 | 1 | 2017 | 306 | 0.52 | Why? |
| Silicon | 1 | 2013 | 31 | 0.51 | Why? |
| Myocytes, Smooth Muscle | 1 | 2014 | 127 | 0.50 | Why? |
| Bacterial Proteins | 2 | 2018 | 1318 | 0.44 | Why? |
| Ascorbic Acid | 1 | 2017 | 676 | 0.44 | Why? |
| Teaching | 1 | 2018 | 1208 | 0.38 | Why? |
| Bacteremia | 2 | 2019 | 1372 | 0.38 | Why? |
| Anti-HIV Agents | 2 | 2020 | 2209 | 0.36 | Why? |
| Needs Assessment | 1 | 2018 | 2352 | 0.36 | Why? |
| Cell Proliferation | 2 | 2017 | 1973 | 0.34 | Why? |
| Cell Differentiation | 2 | 2017 | 1338 | 0.34 | Why? |
| Tuberculosis, Pulmonary | 1 | 2018 | 1171 | 0.34 | Why? |
| Schizophrenia | 1 | 2017 | 1018 | 0.33 | Why? |
| Diet | 1 | 2017 | 2052 | 0.28 | Why? |
| Renal Insufficiency, Chronic | 1 | 2018 | 2654 | 0.26 | Why? |
| Shock, Septic | 3 | 2018 | 1313 | 0.26 | Why? |
| Logistic Models | 1 | 2017 | 9089 | 0.23 | Why? |
| Neurons | 2 | 2018 | 864 | 0.23 | Why? |
| APACHE | 2 | 2021 | 682 | 0.22 | Why? |
| Drosophila Proteins | 1 | 2021 | 67 | 0.21 | Why? |
| Respiratory Tract Infections | 1 | 2021 | 6817 | 0.21 | Why? |
| Anti-Bacterial Agents | 2 | 2019 | 10083 | 0.20 | Why? |
| Critical Illness | 2 | 2021 | 17281 | 0.20 | Why? |
| Antibiotics, Antineoplastic | 2 | 2017 | 128 | 0.20 | Why? |
| KATP Channels | 1 | 2018 | 2 | 0.19 | Why? |
| Trigeminal Ganglion | 1 | 2018 | 14 | 0.19 | Why? |
| Syringomyelia | 1 | 2018 | 4 | 0.19 | Why? |
| Seoul | 1 | 2019 | 206 | 0.19 | Why? |
| Bupivacaine | 1 | 2018 | 24 | 0.19 | Why? |
| Nafcillin | 1 | 2018 | 4 | 0.19 | Why? |
| Spacecraft | 1 | 2018 | 21 | 0.19 | Why? |
| Alcohol Dehydrogenase | 1 | 2018 | 19 | 0.19 | Why? |
| Potassium Channels | 1 | 2018 | 33 | 0.19 | Why? |
| Lupus Erythematosus, Discoid | 1 | 2018 | 24 | 0.19 | Why? |
| Verapamil | 1 | 2018 | 46 | 0.19 | Why? |
| Neuromuscular Blockade | 1 | 2018 | 66 | 0.18 | Why? |
| Digestive System Abnormalities | 1 | 2018 | 18 | 0.18 | Why? |
| Biodegradation, Environmental | 1 | 2018 | 52 | 0.18 | Why? |
| Linoleic Acid | 1 | 2018 | 65 | 0.18 | Why? |
| Sacrum | 1 | 2018 | 41 | 0.18 | Why? |
| Lithium Chloride | 1 | 2017 | 14 | 0.18 | Why? |
| Rats, Sprague-Dawley | 3 | 2018 | 987 | 0.18 | Why? |
| Acinetobacter | 1 | 2018 | 58 | 0.18 | Why? |
| Protein Hydrolysates | 1 | 2017 | 15 | 0.18 | Why? |
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2017 | 1 | 0.18 | Why? |
| Doxorubicin | 2 | 2017 | 313 | 0.18 | Why? |
| Invertebrates | 1 | 2017 | 21 | 0.18 | Why? |
| Lysogeny | 1 | 2017 | 5 | 0.17 | Why? |
| Homeodomain Proteins | 1 | 2018 | 93 | 0.17 | Why? |
| Cholera Toxin | 1 | 2017 | 27 | 0.17 | Why? |
| Chromosomes, Bacterial | 1 | 2017 | 18 | 0.17 | Why? |
| Azacitidine | 1 | 2017 | 42 | 0.17 | Why? |
| Chlorides | 1 | 2017 | 82 | 0.17 | Why? |
| Tandem Repeat Sequences | 1 | 2017 | 78 | 0.17 | Why? |
| Histiocytic Necrotizing Lymphadenitis | 1 | 2017 | 23 | 0.17 | Why? |
| Gastrectomy | 1 | 2018 | 225 | 0.17 | Why? |
| Luminescent Proteins | 1 | 2017 | 142 | 0.16 | Why? |
| Minerals | 1 | 2017 | 86 | 0.16 | Why? |
| Tuberculosis, Miliary | 1 | 2017 | 66 | 0.16 | Why? |
| Valproic Acid | 1 | 2017 | 114 | 0.16 | Why? |
| Erythrocyte Indices | 1 | 2018 | 207 | 0.16 | Why? |
| Antimetabolites, Antineoplastic | 1 | 2017 | 99 | 0.16 | Why? |
| Influenza, Human | 1 | 2021 | 10779 | 0.16 | Why? |
| Transduction, Genetic | 1 | 2017 | 273 | 0.15 | Why? |
| Urinalysis | 1 | 2017 | 218 | 0.15 | Why? |
| Vasodilation | 1 | 2018 | 258 | 0.15 | Why? |
| Nutrition Policy | 1 | 2017 | 132 | 0.15 | Why? |
| Sarcopenia | 1 | 2021 | 422 | 0.15 | Why? |
| Glycopeptides | 1 | 2018 | 199 | 0.15 | Why? |
| Prognosis | 6 | 2021 | 32490 | 0.15 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.15 | Why? |
| Hippocampus | 1 | 2017 | 237 | 0.15 | Why? |
| Virus Replication | 1 | 2017 | 14331 | 0.15 | Why? |
| Rhinovirus | 1 | 2021 | 979 | 0.15 | Why? |
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 245 | 0.14 | Why? |
| Anal Canal | 1 | 2018 | 367 | 0.14 | Why? |
| Calcium Channel Blockers | 1 | 2018 | 367 | 0.14 | Why? |
| Diastole | 1 | 2015 | 168 | 0.14 | Why? |
| Genome, Viral | 1 | 2017 | 13157 | 0.14 | Why? |
| Pleural Effusion | 1 | 2021 | 680 | 0.14 | Why? |
| Cell Survival | 3 | 2017 | 1581 | 0.14 | Why? |
| Rectum | 1 | 2018 | 495 | 0.14 | Why? |
| Gene Expression | 2 | 2017 | 3332 | 0.14 | Why? |
| Lactic Acid | 1 | 2017 | 393 | 0.14 | Why? |
| Systole | 1 | 2015 | 252 | 0.13 | Why? |
| Retrospective Studies | 13 | 2021 | 105322 | 0.13 | Why? |
| Bacteriophages | 1 | 2017 | 268 | 0.13 | Why? |
| Bone Marrow | 1 | 2017 | 492 | 0.13 | Why? |
| Plasmids | 1 | 2017 | 840 | 0.13 | Why? |
| Silicates | 1 | 2013 | 19 | 0.13 | Why? |
| RANK Ligand | 1 | 2013 | 47 | 0.13 | Why? |
| Oligopeptides | 1 | 2017 | 576 | 0.13 | Why? |
| Collagen Type I | 1 | 2013 | 56 | 0.13 | Why? |
| Stomach Neoplasms | 1 | 2018 | 477 | 0.12 | Why? |
| Enzyme Activation | 1 | 2014 | 425 | 0.12 | Why? |
| Male | 21 | 2021 | 367725 | 0.12 | Why? |
| Antidepressive Agents | 1 | 2017 | 509 | 0.12 | Why? |
| Insulin-Like Growth Factor I | 1 | 2013 | 119 | 0.12 | Why? |
| Anti-Asthmatic Agents | 1 | 2017 | 427 | 0.12 | Why? |
| Alkaline Phosphatase | 1 | 2013 | 257 | 0.11 | Why? |
| HEK293 Cells | 4 | 2018 | 8394 | 0.11 | Why? |
| Middle Aged | 15 | 2021 | 270681 | 0.11 | Why? |
| Overweight | 1 | 2017 | 916 | 0.11 | Why? |
| PPAR gamma | 1 | 2011 | 102 | 0.11 | Why? |
| Humans | 33 | 2021 | 930598 | 0.11 | Why? |
| Female | 21 | 2021 | 380317 | 0.10 | Why? |
| Rats | 2 | 2018 | 2764 | 0.10 | Why? |
| Membrane Proteins | 1 | 2021 | 1733 | 0.10 | Why? |
| Systemic Inflammatory Response Syndrome | 2 | 2021 | 6653 | 0.10 | Why? |
| Sputum | 1 | 2018 | 1720 | 0.10 | Why? |
| Drug Resistance, Bacterial | 1 | 2019 | 1414 | 0.10 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2018 | 1164 | 0.09 | Why? |
| Antipsychotic Agents | 1 | 2017 | 887 | 0.09 | Why? |
| Diarrhea | 1 | 2021 | 2743 | 0.09 | Why? |
| Staphylococcal Infections | 1 | 2018 | 1099 | 0.09 | Why? |
| Vitamins | 1 | 2017 | 1208 | 0.09 | Why? |
| Cell Line | 2 | 2014 | 12040 | 0.09 | Why? |
| Treatment Outcome | 5 | 2021 | 51732 | 0.09 | Why? |
| Multiple Myeloma | 1 | 2017 | 1064 | 0.08 | Why? |
| Aged | 11 | 2021 | 215776 | 0.08 | Why? |
| Obesity | 2 | 2018 | 7388 | 0.08 | Why? |
| Laparoscopy | 1 | 2018 | 1532 | 0.08 | Why? |
| Tertiary Care Centers | 3 | 2019 | 8248 | 0.08 | Why? |
| Nutritional Status | 1 | 2017 | 1403 | 0.08 | Why? |
| Lupus Erythematosus, Systemic | 1 | 2018 | 1380 | 0.08 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.08 | Why? |
| Hematologic Neoplasms | 1 | 2019 | 2105 | 0.08 | Why? |
| Adult | 11 | 2020 | 244371 | 0.07 | Why? |
| Antibodies, Antinuclear | 2 | 2018 | 234 | 0.07 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.07 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.07 | Why? |
| Mice | 5 | 2018 | 21357 | 0.07 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.07 | Why? |
| Adrenal Cortex Hormones | 1 | 2021 | 6537 | 0.07 | Why? |
| Dose-Response Relationship, Drug | 1 | 2013 | 3776 | 0.06 | Why? |
| Risk Factors | 4 | 2021 | 71621 | 0.06 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.06 | Why? |
| Polymerase Chain Reaction | 1 | 2018 | 6740 | 0.06 | Why? |
| Follow-Up Studies | 2 | 2018 | 17020 | 0.06 | Why? |
| Immunocompromised Host | 1 | 2019 | 5150 | 0.06 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.06 | Why? |
| Breast Neoplasms | 2 | 2017 | 3633 | 0.06 | Why? |
| Animals | 7 | 2018 | 78931 | 0.06 | Why? |
| Extracorporeal Membrane Oxygenation | 1 | 2021 | 5002 | 0.06 | Why? |
| Pneumonia, Viral | 2 | 2020 | 243684 | 0.06 | Why? |
| Neutrophils | 1 | 2018 | 5476 | 0.06 | Why? |
| Case-Control Studies | 1 | 2020 | 17671 | 0.06 | Why? |
| Sepsis | 1 | 2018 | 3517 | 0.05 | Why? |
| Proportional Hazards Models | 3 | 2018 | 6543 | 0.05 | Why? |
| Cohort Studies | 3 | 2019 | 36005 | 0.05 | Why? |
| Mutation | 2 | 2021 | 12376 | 0.05 | Why? |
| Age Factors | 1 | 2021 | 21039 | 0.05 | Why? |
| Comorbidity | 2 | 2021 | 34796 | 0.05 | Why? |
| Cromakalim | 1 | 2018 | 1 | 0.05 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.05 | Why? |
| Drug Evaluation, Preclinical | 1 | 2011 | 3347 | 0.05 | Why? |
| Patch-Clamp Techniques | 1 | 2018 | 49 | 0.05 | Why? |
| Nifedipine | 1 | 2018 | 27 | 0.05 | Why? |
| Membrane Potentials | 1 | 2018 | 56 | 0.05 | Why? |
| Genistein | 1 | 2018 | 25 | 0.05 | Why? |
| Maleimides | 1 | 2018 | 21 | 0.05 | Why? |
| Leukocytosis | 1 | 2021 | 280 | 0.05 | Why? |
| Protein Kinase C | 1 | 2018 | 58 | 0.05 | Why? |
| Codon, Nonsense | 1 | 2018 | 66 | 0.05 | Why? |
| Intensive Care Units | 3 | 2020 | 29594 | 0.05 | Why? |
| Emulsions | 1 | 2018 | 80 | 0.05 | Why? |
| Protein Stability | 1 | 2021 | 756 | 0.05 | Why? |
| Pandemics | 3 | 2021 | 389249 | 0.05 | Why? |
| Nickel | 1 | 2018 | 55 | 0.05 | Why? |
| Asthma | 1 | 2017 | 4383 | 0.04 | Why? |
| Hyperlactatemia | 1 | 2017 | 13 | 0.04 | Why? |
| Pregnancy Rate | 1 | 2018 | 134 | 0.04 | Why? |
| Methicillin | 1 | 2018 | 73 | 0.04 | Why? |
| Cell Line, Tumor | 2 | 2017 | 3608 | 0.04 | Why? |
| Frameshift Mutation | 1 | 2018 | 158 | 0.04 | Why? |
| bcl-2-Associated X Protein | 1 | 2017 | 45 | 0.04 | Why? |
| Kaplan-Meier Estimate | 2 | 2017 | 4260 | 0.04 | Why? |
| Renal Dialysis | 1 | 2015 | 4358 | 0.04 | Why? |
| Ovalbumin | 1 | 2017 | 84 | 0.04 | Why? |
| Wnt Proteins | 1 | 2017 | 38 | 0.04 | Why? |
| Detergents | 1 | 2018 | 107 | 0.04 | Why? |
| Live Birth | 1 | 2018 | 200 | 0.04 | Why? |
| 2-Propanol | 1 | 2018 | 109 | 0.04 | Why? |
| Animal Feed | 1 | 2017 | 72 | 0.04 | Why? |
| MCF-7 Cells | 1 | 2017 | 199 | 0.04 | Why? |
| beta Catenin | 1 | 2017 | 78 | 0.04 | Why? |
| Mitogen-Activated Protein Kinases | 1 | 2017 | 126 | 0.04 | Why? |
| Caspase 3 | 1 | 2017 | 218 | 0.04 | Why? |
| C-Reactive Protein | 3 | 2018 | 7972 | 0.04 | Why? |
| Mitral Valve Insufficiency | 1 | 2021 | 302 | 0.04 | Why? |
| Phenotype | 2 | 2018 | 4037 | 0.04 | Why? |
| Hydroxychloroquine | 1 | 2020 | 12447 | 0.04 | Why? |
| Blood Sedimentation | 1 | 2018 | 508 | 0.04 | Why? |
| DNA Mutational Analysis | 1 | 2018 | 581 | 0.04 | Why? |
| Respiration, Artificial | 1 | 2021 | 22116 | 0.04 | Why? |
| Inhibitory Concentration 50 | 1 | 2018 | 907 | 0.04 | Why? |
| Genetic Association Studies | 1 | 2018 | 559 | 0.04 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2017 | 310 | 0.03 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.03 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2017 | 9706 | 0.03 | Why? |
| Random Allocation | 1 | 2017 | 773 | 0.03 | Why? |
| Muscle, Skeletal | 1 | 2021 | 915 | 0.03 | Why? |
| Microbial Viability | 1 | 2018 | 406 | 0.03 | Why? |
| Aged, 80 and over | 2 | 2021 | 88759 | 0.03 | Why? |
| Drug Resistance, Neoplasm | 1 | 2017 | 447 | 0.03 | Why? |
| Calcium | 1 | 2018 | 708 | 0.03 | Why? |
| Hydrogen Peroxide | 1 | 2018 | 680 | 0.03 | Why? |
| Personal Protective Equipment | 1 | 2017 | 15978 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Ethanol | 1 | 2018 | 533 | 0.03 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 13720 | 0.03 | Why? |
| Nuclear Receptor Coactivator 1 | 1 | 2011 | 2 | 0.03 | Why? |
| Ventricular Dysfunction, Left | 1 | 2021 | 993 | 0.03 | Why? |
| Mutation, Missense | 1 | 2018 | 863 | 0.03 | Why? |
| 3T3-L1 Cells | 1 | 2011 | 29 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Adipogenesis | 1 | 2011 | 38 | 0.03 | Why? |
| Platelet Count | 1 | 2018 | 1381 | 0.03 | Why? |
| Ultrasonography | 2 | 2021 | 4409 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2018 | 1999 | 0.03 | Why? |
| Lipids | 1 | 2018 | 1079 | 0.03 | Why? |
| Molecular Weight | 1 | 2011 | 249 | 0.03 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.03 | Why? |
| Body Weight | 1 | 2017 | 1074 | 0.03 | Why? |
| Exanthema | 1 | 2021 | 1097 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2018 | 43792 | 0.03 | Why? |
| Reactive Oxygen Species | 1 | 2017 | 1136 | 0.03 | Why? |
| Anemia | 1 | 2018 | 789 | 0.03 | Why? |
| Transcriptional Activation | 1 | 2011 | 196 | 0.03 | Why? |
| Protein Conformation | 1 | 2021 | 4386 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Liver Function Tests | 1 | 2017 | 1325 | 0.03 | Why? |
| Sex Factors | 2 | 2018 | 11014 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2015 | 11497 | 0.02 | Why? |
| Indoles | 1 | 2018 | 1243 | 0.02 | Why? |
| NF-kappa B | 1 | 2017 | 1301 | 0.02 | Why? |
| Disease Outbreaks | 1 | 2017 | 27595 | 0.02 | Why? |
| Equipment Contamination | 1 | 2018 | 1308 | 0.02 | Why? |
| Cell Death | 1 | 2011 | 536 | 0.02 | Why? |
| L-Lactate Dehydrogenase | 1 | 2017 | 1995 | 0.02 | Why? |
| Binding Sites | 1 | 2021 | 6201 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Protein Domains | 1 | 2021 | 6563 | 0.02 | Why? |
| Molecular Dynamics Simulation | 1 | 2021 | 4155 | 0.02 | Why? |
| Double-Blind Method | 1 | 2018 | 5988 | 0.02 | Why? |
| Health Personnel | 1 | 2017 | 29646 | 0.02 | Why? |
| Young Adult | 4 | 2018 | 93724 | 0.02 | Why? |
| Antiviral Agents | 1 | 2020 | 41703 | 0.02 | Why? |
| Recombinant Proteins | 1 | 2017 | 3786 | 0.02 | Why? |
| Multivariate Analysis | 1 | 2017 | 5440 | 0.02 | Why? |
| Mice, Inbred C57BL | 1 | 2017 | 5542 | 0.02 | Why? |
| Blood Donors | 1 | 2020 | 2956 | 0.02 | Why? |
| Ligands | 1 | 2011 | 1300 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2021 | 7220 | 0.02 | Why? |
| Betacoronavirus | 2 | 2020 | 204454 | 0.02 | Why? |
| ROC Curve | 1 | 2018 | 6024 | 0.02 | Why? |
| Dexamethasone | 1 | 2017 | 2055 | 0.02 | Why? |
| Molecular Docking Simulation | 1 | 2021 | 6902 | 0.02 | Why? |
| Skin | 1 | 2018 | 2096 | 0.02 | Why? |
| Adolescent | 3 | 2021 | 86841 | 0.02 | Why? |
| Tomography, X-Ray Computed | 2 | 2021 | 25144 | 0.02 | Why? |
| Patient Selection | 1 | 2018 | 4560 | 0.02 | Why? |
| Predictive Value of Tests | 1 | 2018 | 9537 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.02 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2018 | 5164 | 0.01 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Viral Load | 1 | 2020 | 15850 | 0.01 | Why? |
| Disease Models, Animal | 1 | 2017 | 10998 | 0.01 | Why? |
| Models, Molecular | 1 | 2011 | 7616 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.01 | Why? |
| Heart Failure | 1 | 2017 | 6638 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Cross Infection | 1 | 2018 | 8675 | 0.01 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.01 | Why? |
| Incidence | 1 | 2017 | 25622 | 0.01 | Why? |
| Protein Binding | 1 | 2011 | 11430 | 0.01 | Why? |
| Child, Preschool | 1 | 2018 | 36283 | 0.01 | Why? |
| China | 1 | 2020 | 50654 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2017 | 14232 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Hospitalization | 1 | 2021 | 54280 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2017 | 53120 | 0.01 | Why? |